Physician profile
Dmitri V Gelfand
NPI 1205093176
$3,742.59
in general payments reported to CMS, 2019-2025
13 companies · $851 in 2025
The $851 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $29.90 · 2021: $32.71 · 2022: $330 · 2023: $1,031 · 2024: $654 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,299 · Travel and Lodging: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,299.11 |
| Travel and Lodging | $237.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $943.26 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $849.49 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Boston Scientific Corporation | $397.61 | 2019-2025 | Eluvia |
| Siemens Medical Solutions USA, INC. | $301.85 | 2023 | Artis Pheno |
| Endologix LLC | $295.28 | 2025 | Alto Abdominal Stent Graft System |
| Lemaitre Vascular, INC. | $209.64 | 2019-2025 | Restoreflow, Artegraft Vascular Graft |
| Cook Medical LLC | $200.66 | 2019-2025 | Zenith, Rosen |
| Medtronic, INC. | $168.93 | 2023 | Endurant Iis |
| Shockwave Medical, INC | $155.58 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $79.00 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Artivion, INC. | $63.33 | 2019 | |
| Bard Peripheral Vascular, INC. | $45.28 | 2021-2022 | |
| Angiodynamics, INC. | $32.68 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitri Gelfand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.